ObjectivesAs a switch from chemokine (C-C motif) receptor 5 [CCR5 (R5)] to chemokine (C-X-C motif) receptor 4 [CXCR4 (X4)] HIV-1 tropism is associated with symptomatic and AIDS stages of infection, while chemokine receptor gene variants modify the tempo of HIV disease progression, we aimed to analyse the association between pretreatment HIV-1 tropism and chemokine polymorphisms known to restrict disease progression.
MethodsV3 genotype tropism prediction was performed in a group of 221 treatment-naïve patients, with subsequent CCR5 Δ32 (rs333), CCR2 V64I (rs1799864), CCR5 promoter (−627 C/T; rs1799988) and CX3CR1 V249I (rs3732378) genotyping performed in 206 patients. Alleles with a protective effect were assigned positive values while risk alleles were assigned negative values to calculate genetic scores. χ 2 tests, Mann−Whitney U-tests and logistic and linear regression models were used for statistical analyses.
ResultsR5 tropism was found in 85.5% of patients (n = 189) using a false positive rate (FPR) of 5.75% and in 72.8% of patients (n = 161) using an FPR of 10%. A higher frequency of the 5.75% FPR predicted R5 tropism was associated with the CX3CR1 A allele (P = 0.027). Lower additive genetic scores were associated with an increased frequency of 5.75% FPR predicted R5 tropism (P = 0.0059), with the trend confirmed by logistic regression [odds ratio (OR) 0.5819; 95% confidence interval (CI) 0.3457-0.9795; P = 0.0416]. Viral load tended to increase with decreasing genetic score in the logistic regression analysis (slope = −0.127 ± 0.076; P = 0.095; r 2 = 0.161).
ConclusionsThe CX3CR1 A allele and lower genetic scores may restrict the switch of HIV-1 tropism from R5 to X4. This effect may be associated with the amount of co-receptor on the cell surface. Chemokine receptor gene polymorphisms influence both disease progression and tropism variability.Keywords: chemokine receptor variants, chemokines, HIV tropism, host genetics.
Accepted 26 February 2014
IntroductionStudies on the interaction of HIV with chemokine receptors have resulted in the identification of the chemokine (C-C motif) receptor 5 [CCR5 (R5)], chemokine (C-X-C motif) receptor 4 [CXCR4 (X4)] and dual-mixed (D/M) tropic viral populations. R5 is associated with early stages of infection and is preferentially transmitted, while X4 HIV-1 tropism has been associated with symptomatic and AIDS stages of infection, severe immunodeficiency and a lower lymphocyte CD4 nadir [1,2]. Sequencing of the third hypervariable loop and association of sequence data with phenotypic tropism analyses have led to the development of efficient tropism prediction tools based on the genetic sequence [3][4][5][6]. Currently, it is required to identify HIV-1 tropism prior to CCR5 inhibitor use, and according to European guidelines both genotypic and phenotypic prediction tools may be used [7]. From the perspective of host genetic variability, several chemokine receptor genes associated with differences in cell surface HIV co-receptor expression have been associated with modi...